Diisooctyl Phthalate Isolated from Rourea mimosoides: A Partial PPARγ Agonist Potently Blocks Adipocyte Differentiation doi.org/10.26538/tjnpr/v6i8.6
Main Article Content
Abstract
Type II diabetes mellitus (T2DM) is a metabolic disorder due to the development of insulin resistant caused by the modification of insulin signalling, resulting in a reduction in glucose uptake in myocytes, hepatocytes, adipocytes, and elevation of blood glucose levels. Thiazolidinediones (TZDs) are medications used in the treatment of T2DM. The primary target of TZDs is the peroxisome proliferator-activated receptor-gamma (PPAR-γ), a key regulator of adipogenesis and glucose homeostasis. In this study, extracts from Malaysian plants were tested in a screening platform which includes tests for adipocyte differentiation, insulin-stimulated glucose uptake and PPAR-γ transactivation. A total of 122 plant extracts collected from Royal Belum Rainforest, Malaysia were tested on adipocyte differentiation, glucose uptake and PPAR-transcription assays. Rourea mimosoides was found to inhibit the adipocyte differentiation and showed the ability to enhance the glucose uptake in C2C12 myoblast cells as well as active to promote the transcription of PPAR-γ. A bioactive compound designated as compound 1 was isolated from this plant and was identified as Diisooctyl phthalate. The biological activities (adipocyte differentiation and PPAR-γ transactivation) of this compound were demonstrated and compound 1 was found to possess the ability to trigger expression of PPAR-γ in HepG2 cells.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Wang L, Waltenberger B, Pferschy-Wenzig E-M, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, Schuster D, Kopp B, Bauer R, Stuppner H, Dirsch VM, Atanasov AG. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol. 2014; 92(1):73-89.
Van Marrewijk LM, . Polyak SW, Hijnen M, Kuruvilla D, Chang MR, Shin Y, Kamenecka TM, Griffin PR, Bruning JB. SR2067 Reveals a Unique Kinetic and StructuralSignature for PPARγ Partial Agonism. ACS Chem. Biol. 2016; 11:273-283.
Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM. PPARγ signaling and metabolism: the good, the bad and the future. Nature Med. 2013; 19:557-566.
Hyo JG, Yong-S C, Hua L, Yoon-J K, Jae-H R, Jeon R. Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach. Int J Mol Sci. 2018; 19: 3032.
Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review. Nutr J. 2014; 13:17.
Soonkyu C, Young JK, Soo JY, Yunkyoung L, Myoungsook L. Nutrigenomic Functions of PPARs in Obesogenic Environments. PPAR Res. 2016; 2016: Article ID 4794576:17 pages.
Kroker A J and Bruning JB. Review of the Structural and Dynamic Mechanisms of PPAR Partial Agonism. PPAR Res. 2015; 2015: Article ID 816856:15 pages.
Christensen LP and El-Houri RB. Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds. Mol. 2018; 23:2431.
Natural Compound 3β,7β,25-trihydroxycucurbita-5,23(E)-dien-19-al from Momordica charantia Acts as PPARγLigand. Ahmad Noruddin N A, Hamzah M F, Rosman Z, Salin N H, Shu-Chien A C and Tengku Muhammad T S. Mol. 2021; 26:2682.
Wong CY, Al-Salamia H, Crispin R. Dassa. C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage. J Pharm Pharmacol. 2020; 72(12):1667.
Osman CP, Zahari Z, Adenan MI, Mohd Zohdi R. A review on traditional uses, phytochemistry, and pharmacology of the genus Rourea. J Appl Pharm Sci. 2019; 9(09):125.
Sabran SF, Mohamed M, Abu Bakar MF. Ethnobotany: A Living Science for Alleviating Human Suffering. Evid-Based Compl Altern Med. 2016; 2016, Article ID 2850845:12 pages.
Fadipe LA, Haruna K, Mohammed I. Antibacterial activity of 1, 2- benzenedicarboxylic acid, dioctyl ester isolated from the ethyl acetate soluble sub-portion of the unripe fruits of Nauclea latifolia. Int J Appl Biosci. 2014; 2(1):223.
Aranaz P, Navarro-Herrera D, Zabala M, Miguéliz I, Romo-Hualde A, López-Yoldi MJ. Martínez A, Vizmanos JL, Milagro FI, González-Navarro CJ. Phenolic Compounds Inhibit 3T3-L1 Adipogenesis Depending on the Stage of Differentiation and Their Binding Affinity to PPARγ. Mol. 2019; 24(6):1045.
Fan H, Pan S, Yuan G, Pengfei X, Yonggong Z. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism. Mol. 2019; 24(14), 2545.
Desvergne B, Feige JN, Casals-Casas C. PPAR-mediated activity of phthalates: A link to the obesity epidemic? Mol Cellul Endocrinol. 2009; 304:43-48.
Hurst CH and Waxman DJ. Activation of PPARα and PPARγ by Environmental Phthalate Monoesters. Toxicol Sci. 2003; 74(2):297-308.
Roy RN. Bioactive natural derivatives of phthalate ester. Crit Rev Biotechnol. 2020; 40(7):913-929.
Carlson KR and Patton LE. Report Commission pursuant to contract CPSC-D-06-0006. [Online]. 2010 [cited 2021 Nov
. Available from: https://www.researchgate.net/publication/281275585_Toxic ity_review_of_ditridecyl_phthalate_DTDP.